Cite
Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases
MLA
Stephen W. Byers, et al. “Bioinformatics Analysis Reveals Transcriptome and MicroRNA Signatures and Drug Repositioning Targets for IBD and Other Autoimmune Diseases.” Inflammatory Bowel Diseases, vol. 18, Dec. 2012, pp. 2315–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....37d99999ada458bb1b5a81dff6103019&authtype=sso&custid=ns315887.
APA
Stephen W. Byers, Will Dampier, Peter Clark, Aydin Tozeren, Noor Dawany, & Richard G. Pestell. (2012). Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases. Inflammatory Bowel Diseases, 18, 2315–2333.
Chicago
Stephen W. Byers, Will Dampier, Peter Clark, Aydin Tozeren, Noor Dawany, and Richard G. Pestell. 2012. “Bioinformatics Analysis Reveals Transcriptome and MicroRNA Signatures and Drug Repositioning Targets for IBD and Other Autoimmune Diseases.” Inflammatory Bowel Diseases 18 (December): 2315–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....37d99999ada458bb1b5a81dff6103019&authtype=sso&custid=ns315887.